PharmaCyte Biotech, Inc.
PMCB
$1.67
$0.031.83%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -36.14% | -34.96% | -18.02% | -16.64% | -1.66% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 105.33% | -7.54% | -12.76% | -7.86% | 264.37% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -35.11% | -34.82% | -17.99% | -16.60% | -1.34% |
|
|
|||||
| Total Current Assets | -35.11% | -34.82% | -17.99% | -16.60% | -1.34% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | -56.35% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.69% | -15.98% | 67.34% | 61,324.68% | 0.00% |
| Total Assets | -21.51% | 17.18% | -16.05% | -9.53% | -1.26% |
|
|
|||||
| Total Accounts Payable | -37.08% | 42.27% | -19.58% | 283.68% | -82.43% |
| Total Accrued Expenses | 3.38% | -6.95% | -5.06% | -23.94% | 112.13% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -40.33% | 1,245.47% | -53.24% | 72.53% | 79.61% |
| Total Other Current Liabilities | -40.33% | 1,245.47% | -53.24% | 72.53% | 79.61% |
| Total Current Liabilities | -36.09% | 370.62% | -29.42% | 30.89% | 13.23% |
|
|
|||||
| Total Current Liabilities | -36.09% | 370.62% | -29.42% | 30.89% | 13.23% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -29.02% | -25.35% | -13.12% | -4.15% | -17.51% |
| Total Liabilities | -32.10% | 17.84% | -15.26% | -0.67% | -15.22% |
|
|
|||||
| Common Stock & APIC | -0.75% | -1.41% | -2.05% | -2.26% | -4.27% |
| Retained Earnings | -1.59% | 20.26% | 1.15% | -0.53% | 2.60% |
| Treasury Stock & Other | -3.31% | -1.78% | -2.90% | -1.00% | -1.08% |
| Total Common Equity | -8.92% | 72.56% | -11.88% | -14.67% | -13.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | 10.29% | 50.22% | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -55.06% | -32.26% | -17.74% | 27.13% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -69.87% | -22.39% | -8.10% | 48.14% |
|
|
|||||
| Total Common Equity | -8.92% | 72.56% | -11.88% | -14.67% | -13.95% |
| Total Preferred Equity | -- | -69.87% | -22.39% | -8.10% | 48.14% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.08% | 16.97% | -16.31% | -12.02% | 3.53% |
|
|
|||||
